Erenxa Files to Raise Up to $300M
Erenxa Therapeutics filed a registration statement with the SEC to raise up to $300 million in an underwritten public offering, aimed at funding its clinical pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed